{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# COVID 19 Vaccines"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This notebook is to practice storytelling skills using COVID-19 vaccines dataset from [The Milken Institute's FasterCures project](https://covid-19tracker.milkeninstitute.org/#about). \n",
    "\n",
    "Main questions:\n",
    "* How many vaccines have been tracked?\n",
    "* What platforms have been used to build vaccines?\n",
    "* What phases are the vaccines in?\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# load basic libraries\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# load dataset\n",
    "vac = pd.read_csv('COVID-19 Tracker-Vaccines.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Developer / Researcher</th>\n",
       "      <th>Treatment vs. Vaccine</th>\n",
       "      <th>Product Category</th>\n",
       "      <th>Stage of Development</th>\n",
       "      <th>Anticipated Next Steps</th>\n",
       "      <th>Product Description</th>\n",
       "      <th>Clinical Trials for COVID-19</th>\n",
       "      <th>Funder</th>\n",
       "      <th>Published Results</th>\n",
       "      <th>Clinical Trials for Other Diseases (T only) / Related Use or Platform (V only)</th>\n",
       "      <th>FDA-Approved Indications</th>\n",
       "      <th>Sources</th>\n",
       "      <th>Date Last Updated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Genexine Consortium (GenNBio, International Va...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>DNA-based</td>\n",
       "      <td>Phase I/II</td>\n",
       "      <td>Phase I/II study: Phase I began end of June 20...</td>\n",
       "      <td>DNA; (GX-19)</td>\n",
       "      <td>NCT04445389</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>9/29/2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Inovio Pharmaceuticals/ Beijing Advaccine Biot...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>DNA-based</td>\n",
       "      <td>Phase I/II</td>\n",
       "      <td>FDA partial clinical hold for planned Phase II...</td>\n",
       "      <td>DNA; (INO-4800) plasmid vaccine with electropo...</td>\n",
       "      <td>NCT04336410, NCT04447781</td>\n",
       "      <td>Coalition for Epidemic Preparedness (CEPI) / G...</td>\n",
       "      <td>Inovio (http://ir.inovio.com/news-releases/new...</td>\n",
       "      <td>Same platform as multiple vaccine candidates</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>9/28/2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Osaka University/ AnGes/ Takara Bio/ Cytiva/ B...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>DNA-based</td>\n",
       "      <td>Phase I/II</td>\n",
       "      <td>Phase I/II began end of June 2020, results exp...</td>\n",
       "      <td>DNA; (AG0301 &amp; AG0302) plasmid vaccine + adjuv...</td>\n",
       "      <td>NCT04463472, NCT04527081</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>9/23/2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Zydus Cadila Healthcare Limited</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>DNA-based</td>\n",
       "      <td>Phase I/II</td>\n",
       "      <td>Phase I/II study: Phase I began July 2020 and ...</td>\n",
       "      <td>DNA; (ZyCoV-D) plasmid vaccine</td>\n",
       "      <td>CTRI/2020/07/026352</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>9/23/2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BioNet Asia/ Technovalia/ Vax4COVID/ The Unive...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>DNA-based</td>\n",
       "      <td>Pre-clinical</td>\n",
       "      <td>Phase I/Ib expected to be dosed October 2020</td>\n",
       "      <td>DNA; (COVIGEN) needle-free delivery</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Australian Government Medical Research Future ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>10/7/2020</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                              Developer / Researcher Treatment vs. Vaccine  \\\n",
       "0  Genexine Consortium (GenNBio, International Va...               Vaccine   \n",
       "1  Inovio Pharmaceuticals/ Beijing Advaccine Biot...               Vaccine   \n",
       "2  Osaka University/ AnGes/ Takara Bio/ Cytiva/ B...               Vaccine   \n",
       "3                   Zydus Cadila Healthcare Limited                Vaccine   \n",
       "4  BioNet Asia/ Technovalia/ Vax4COVID/ The Unive...               Vaccine   \n",
       "\n",
       "  Product Category Stage of Development  \\\n",
       "0        DNA-based           Phase I/II   \n",
       "1        DNA-based           Phase I/II   \n",
       "2        DNA-based           Phase I/II   \n",
       "3        DNA-based           Phase I/II   \n",
       "4        DNA-based         Pre-clinical   \n",
       "\n",
       "                              Anticipated Next Steps  \\\n",
       "0  Phase I/II study: Phase I began end of June 20...   \n",
       "1  FDA partial clinical hold for planned Phase II...   \n",
       "2  Phase I/II began end of June 2020, results exp...   \n",
       "3  Phase I/II study: Phase I began July 2020 and ...   \n",
       "4       Phase I/Ib expected to be dosed October 2020   \n",
       "\n",
       "                                 Product Description  \\\n",
       "0                                       DNA; (GX-19)   \n",
       "1  DNA; (INO-4800) plasmid vaccine with electropo...   \n",
       "2  DNA; (AG0301 & AG0302) plasmid vaccine + adjuv...   \n",
       "3                    DNA; (ZyCoV-D) plasmid vaccine    \n",
       "4                DNA; (COVIGEN) needle-free delivery   \n",
       "\n",
       "  Clinical Trials for COVID-19  \\\n",
       "0                  NCT04445389   \n",
       "1     NCT04336410, NCT04447781   \n",
       "2     NCT04463472, NCT04527081   \n",
       "3          CTRI/2020/07/026352   \n",
       "4                          NaN   \n",
       "\n",
       "                                              Funder  \\\n",
       "0                                            Unknown   \n",
       "1  Coalition for Epidemic Preparedness (CEPI) / G...   \n",
       "2                                            Unknown   \n",
       "3                                            Unknown   \n",
       "4  Australian Government Medical Research Future ...   \n",
       "\n",
       "                                   Published Results  \\\n",
       "0                                                NaN   \n",
       "1  Inovio (http://ir.inovio.com/news-releases/new...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "\n",
       "  Clinical Trials for Other Diseases (T only) / Related Use or Platform (V only)  \\\n",
       "0                                                NaN                               \n",
       "1       Same platform as multiple vaccine candidates                               \n",
       "2                                                NaN                               \n",
       "3                                                NaN                               \n",
       "4                                                NaN                               \n",
       "\n",
       "   FDA-Approved Indications  \\\n",
       "0                       NaN   \n",
       "1                       NaN   \n",
       "2                       NaN   \n",
       "3                       NaN   \n",
       "4                       NaN   \n",
       "\n",
       "                                             Sources Date Last Updated  \n",
       "0  https://docs.google.com/document/d/1Y4nCJJ4njz...         9/29/2020  \n",
       "1  https://docs.google.com/document/d/1Y4nCJJ4njz...         9/28/2020  \n",
       "2  https://docs.google.com/document/d/1Y4nCJJ4njz...         9/23/2020  \n",
       "3  https://docs.google.com/document/d/1Y4nCJJ4njz...         9/23/2020  \n",
       "4  https://docs.google.com/document/d/1Y4nCJJ4njz...         10/7/2020  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vac.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "vac.dropna(how='any',axis=1,inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "vac['Date Last Updated'] = vac['Date Last Updated'].apply(func=lambda x: x.split()[-1])\n",
    "vac['Date Last Updated'] = pd.to_datetime(vac['Date Last Updated'],format='%m/%d/%Y')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 213 entries, 0 to 212\n",
      "Data columns (total 9 columns):\n",
      " #   Column                  Non-Null Count  Dtype         \n",
      "---  ------                  --------------  -----         \n",
      " 0   Developer / Researcher  213 non-null    object        \n",
      " 1   Treatment vs. Vaccine   213 non-null    object        \n",
      " 2   Product Category        213 non-null    object        \n",
      " 3   Stage of Development    213 non-null    object        \n",
      " 4   Anticipated Next Steps  213 non-null    object        \n",
      " 5   Product Description     213 non-null    object        \n",
      " 6   Funder                  213 non-null    object        \n",
      " 7   Sources                 213 non-null    object        \n",
      " 8   Date Last Updated       213 non-null    datetime64[ns]\n",
      "dtypes: datetime64[ns](1), object(8)\n",
      "memory usage: 15.1+ KB\n"
     ]
    }
   ],
   "source": [
    "vac.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/hhl/opt/anaconda3/lib/python3.7/site-packages/ipykernel_launcher.py:1: FutureWarning: Treating datetime data as categorical rather than numeric in `.describe` is deprecated and will be removed in a future version of pandas. Specify `datetime_is_numeric=True` to silence this warning and adopt the future behavior now.\n",
      "  \"\"\"Entry point for launching an IPython kernel.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "count                     213\n",
       "unique                     56\n",
       "top       2020-04-20 00:00:00\n",
       "freq                       41\n",
       "first     2020-04-20 00:00:00\n",
       "last      2020-10-09 00:00:00\n",
       "Name: Date Last Updated, dtype: object"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vac['Date Last Updated'].describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## --> As of 10/09/2020, a total of 213 vaccines have been tracked. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# What platforms have been used to develop vaccines against COVID-19? "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Protein subunit                 71\n",
       "RNA-based vaccine               27\n",
       "Non-replicating viral vector    26\n",
       "Unknown                         18\n",
       "Replicating viral vector        18\n",
       "DNA-based                       17\n",
       "Virus-like particle             16\n",
       "Inactivated virus               14\n",
       "Live attenuated virus            4\n",
       "Replicating bacterial vector     2\n",
       "Name: Product Category, dtype: int64"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vac['Product Category'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Text(0, 0, 'Protein subunit'),\n",
       " Text(1, 0, 'RNA-based vaccine'),\n",
       " Text(2, 0, 'Non-replicating viral vector'),\n",
       " Text(3, 0, 'Unknown'),\n",
       " Text(4, 0, 'Replicating viral vector'),\n",
       " Text(5, 0, 'DNA-based'),\n",
       " Text(6, 0, 'Virus-like particle'),\n",
       " Text(7, 0, 'Inactivated virus'),\n",
       " Text(8, 0, 'Live attenuated virus'),\n",
       " Text(9, 0, 'Replicating bacterial vector')]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x432 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "_, ax = plt.subplots(figsize=(12,6))\n",
    "ax=sns.countplot(x='Product Category',data=vac, order = vac['Product Category'].value_counts().index, ax=ax)\n",
    "ax.set_xticklabels(ax.get_xticklabels(), rotation=45, ha='right', va='top')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# What phases are the vaccines in?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Pre-clinical    178\n",
       "Phase I/II       13\n",
       "Phase I           9\n",
       "Phase III         8\n",
       "Phase II          4\n",
       "Phase II/III      1\n",
       "Name: Stage of Development, dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vac['Stage of Development'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Text(0, 0, 'Pre-clinical'),\n",
       " Text(1, 0, 'Phase I/II'),\n",
       " Text(2, 0, 'Phase I'),\n",
       " Text(3, 0, 'Phase III'),\n",
       " Text(4, 0, 'Phase II'),\n",
       " Text(5, 0, 'Phase II/III')]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x432 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "_, ax = plt.subplots(figsize=(12,6))\n",
    "ax=sns.countplot(x='Stage of Development',data=vac, order = vac['Stage of Development'].value_counts().index, ax=ax)\n",
    "ax.set_xticklabels(ax.get_xticklabels(), rotation=45, ha='right', va='top')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Who are the developers who have Phase III vaccines"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "Phase3 = vac.loc[vac['Stage of Development']=='Phase III',:]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Developer / Researcher</th>\n",
       "      <th>Treatment vs. Vaccine</th>\n",
       "      <th>Product Category</th>\n",
       "      <th>Stage of Development</th>\n",
       "      <th>Anticipated Next Steps</th>\n",
       "      <th>Product Description</th>\n",
       "      <th>Funder</th>\n",
       "      <th>Sources</th>\n",
       "      <th>Date Last Updated</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Beijing Institute of Biological Products/ Sino...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>Inactivated virus</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Phase III trial began July 2020; Received earl...</td>\n",
       "      <td>Inactivated</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-09-28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Sinovac/ Instituto Butantan/ Bio Farma</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>Inactivated virus</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Received approval for Phase I/II trial in adol...</td>\n",
       "      <td>Inactivated (inactivated + alum); CoronaVac (f...</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-09-23</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Wuhan Institute of Biological Products/ Sinopharm</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>Inactivated virus</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Phase III trial began July 2020; Phase I/II ea...</td>\n",
       "      <td>Inactivated</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-09-28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>CanSino Biologics/Beijing Institute of Biotech...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>Non-replicating viral vector</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Phase III dosed September 2020; Phase II began...</td>\n",
       "      <td>Non-replicating viral vector; Adenovirus Type ...</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-09-22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Gamaleya Research Institute</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>Non-replicating viral vector</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Phase III (post-registration) trial began Sept...</td>\n",
       "      <td>Adeno-based, Gam-COVID-Vac Lyo (Sputnik V)</td>\n",
       "      <td>Russian Direct Investment Fund (RDIF)</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-09-28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Janssen Pharmaceutical Companies/ Beth Israel ...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>Non-replicating viral vector</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Phase III trial (ENSEMBLE) began and study pro...</td>\n",
       "      <td>Ad26.COV2-S, Non replicating viral vector; Ad2...</td>\n",
       "      <td>Biomedical Advanced Research and Development A...</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-09-30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>University of Oxford, Oxford Biomedica, Vaccin...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>Non-replicating viral vector</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Study protocol for late-stage clinical trials ...</td>\n",
       "      <td>Non-replicating viral vector; AZD 1222 (former...</td>\n",
       "      <td>Coalition for Epidemic Preparedness Innovation...</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-10-06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>Moderna/ NIAID/ Lonza/ Catalent/ Rovi/ Medidat...</td>\n",
       "      <td>Vaccine</td>\n",
       "      <td>RNA-based vaccine</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>Study protocol for late-stage clinical trials ...</td>\n",
       "      <td>RNA; LNP-encapsulated mRNA (mRNA 1273)</td>\n",
       "      <td>Coalition for Epidemic Preparedness (CEPI)/ Bi...</td>\n",
       "      <td>https://docs.google.com/document/d/1Y4nCJJ4njz...</td>\n",
       "      <td>2020-09-30</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                Developer / Researcher Treatment vs. Vaccine  \\\n",
       "17   Beijing Institute of Biological Products/ Sino...               Vaccine   \n",
       "18              Sinovac/ Instituto Butantan/ Bio Farma               Vaccine   \n",
       "19   Wuhan Institute of Biological Products/ Sinopharm               Vaccine   \n",
       "35   CanSino Biologics/Beijing Institute of Biotech...               Vaccine   \n",
       "36                         Gamaleya Research Institute               Vaccine   \n",
       "37   Janssen Pharmaceutical Companies/ Beth Israel ...               Vaccine   \n",
       "38   University of Oxford, Oxford Biomedica, Vaccin...               Vaccine   \n",
       "150  Moderna/ NIAID/ Lonza/ Catalent/ Rovi/ Medidat...               Vaccine   \n",
       "\n",
       "                 Product Category Stage of Development  \\\n",
       "17              Inactivated virus            Phase III   \n",
       "18              Inactivated virus            Phase III   \n",
       "19              Inactivated virus            Phase III   \n",
       "35   Non-replicating viral vector            Phase III   \n",
       "36   Non-replicating viral vector            Phase III   \n",
       "37   Non-replicating viral vector            Phase III   \n",
       "38   Non-replicating viral vector            Phase III   \n",
       "150             RNA-based vaccine            Phase III   \n",
       "\n",
       "                                Anticipated Next Steps  \\\n",
       "17   Phase III trial began July 2020; Received earl...   \n",
       "18   Received approval for Phase I/II trial in adol...   \n",
       "19   Phase III trial began July 2020; Phase I/II ea...   \n",
       "35   Phase III dosed September 2020; Phase II began...   \n",
       "36   Phase III (post-registration) trial began Sept...   \n",
       "37   Phase III trial (ENSEMBLE) began and study pro...   \n",
       "38   Study protocol for late-stage clinical trials ...   \n",
       "150  Study protocol for late-stage clinical trials ...   \n",
       "\n",
       "                                   Product Description  \\\n",
       "17                                         Inactivated   \n",
       "18   Inactivated (inactivated + alum); CoronaVac (f...   \n",
       "19                                         Inactivated   \n",
       "35   Non-replicating viral vector; Adenovirus Type ...   \n",
       "36          Adeno-based, Gam-COVID-Vac Lyo (Sputnik V)   \n",
       "37   Ad26.COV2-S, Non replicating viral vector; Ad2...   \n",
       "38   Non-replicating viral vector; AZD 1222 (former...   \n",
       "150             RNA; LNP-encapsulated mRNA (mRNA 1273)   \n",
       "\n",
       "                                                Funder  \\\n",
       "17                                             Unknown   \n",
       "18                                             Unknown   \n",
       "19                                             Unknown   \n",
       "35                                             Unknown   \n",
       "36               Russian Direct Investment Fund (RDIF)   \n",
       "37   Biomedical Advanced Research and Development A...   \n",
       "38   Coalition for Epidemic Preparedness Innovation...   \n",
       "150  Coalition for Epidemic Preparedness (CEPI)/ Bi...   \n",
       "\n",
       "                                               Sources Date Last Updated  \n",
       "17   https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-09-28  \n",
       "18   https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-09-23  \n",
       "19   https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-09-28  \n",
       "35   https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-09-22  \n",
       "36   https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-09-28  \n",
       "37   https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-09-30  \n",
       "38   https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-10-06  \n",
       "150  https://docs.google.com/document/d/1Y4nCJJ4njz...        2020-09-30  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Phase3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
